Hemostat Powder and Tissue Sealing Agent Market

Hemostat powder is a medical device used to control bleeding. It is a dry powder that is applied to the affected area and works by promoting blood clotting. A tissue-sealing agent is a liquid that is applied to the affected area and works by forming a barrier between the tissues and the wound, thus preventing further bleeding.

The hemostat powder and tissue sealing agent market is expected to reach USD XX million by 2019 from USD XX  million in 2018, at a CAGR of **%. The increase in demand for hemostats in trauma care and surgery, the development of new hemostats with an advanced mechanism of action, and the rise in the use of fibrin sealants are the major factors driving the growth of this market.

Hemostats are powder or paste-like substances that are used to stop bleeding by physically sealing leaking blood vessels. Tissue sealants are natural or synthetic materials that are used to bind tissues together by forming an insoluble matrix in contact with body fluids without causing any toxic reaction. These agents help in achieving hemostasis during surgical procedures by providing an alternative to conventional methods such as suturing and cautery. Fibrin sealants are one of the most commonly used tissue sealants as they mimic the final stage of the natural blood clotting process.

The global hemostat powder and tissue sealing agent market is segmented by product, application, end-user, and region. Based on product, the market is classified into collagen-based products, gelatin-based products, cellulose-based products, oxidized regenerated cellulose (ORC)-based products, fibrin sealant patches/gels/strips/sheets, cyanoacrylate glue & adhesive bandages, hydrogen.

Hemostat powder and tissue sealing agents are widely used in various surgical procedures such as hemostasis, tissue approximation, and ligation. These agents help in minimizing blood loss during surgery and also act as an antimicrobial barrier. In addition, they also offer hemostatic efficacy for up to 24 hours post-surgery. Some of the key trends observed in the hemostat powder and tissue sealing agent market include the increasing adoption of bioresorbable products. Minimally invasive surgeries help in reducing surgical trauma, blood loss, and recovery time. Bioresorbable products are slowly gaining popularity as they do not require removal after surgery and are completely absorbed by the body over time.